Prelude Capital Management, LLC Singular Genomics Systems, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.82 - $2.71 $5,096 - $7,588
2,800 Added 11.24%
27,700 $55,000
Q3 2022

Nov 14, 2022
SELL
$2.5 - $4.73 $16,625 - $31,454
-6,650 Reduced 21.08%
24,900 $62,000
Q2 2022

Aug 15, 2022
BUY
$2.86 - $6.44 $90,233 - $203,182
31,550 New
31,550 $121,000

Others Institutions Holding OMIC

# of Institutions
2
Shares Held
1.43M
Call Options Held
0
Put Options Held
0
View Full List

About Singular Genomics Systems, Inc.

OMIC Quotes by TradingView
  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $1.52B
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email